SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-006681
Filing Date
2015-08-07
Accepted
2015-08-07 16:28:32
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q srne-10q_20150630.htm 10-Q 1215202
2 EX-10.1 srne-ex101_41.htm EX-10.1 247531
3 EX-10.2 srne-ex102_40.htm EX-10.2 110228
4 EX-31.1 srne-ex311_6.htm EX-31.1 9654
5 EX-31.2 srne-ex312_7.htm EX-31.2 9575
6 EX-32.1 srne-ex321_8.htm EX-32.1 10933
  Complete submission text file 0001564590-15-006681.txt   5059813

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT srne-20150630.xml EX-101.INS 744774
8 XBRL TAXONOMY EXTENSION SCHEMA srne-20150630.xsd EX-101.SCH 45255
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE srne-20150630_cal.xml EX-101.CAL 43810
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE srne-20150630_def.xml EX-101.DEF 160182
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE srne-20150630_lab.xml EX-101.LAB 356630
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srne-20150630_pre.xml EX-101.PRE 273685
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36150 | Film No.: 151037856
SIC: 8731 Services-Commercial Physical & Biological Research